[
  {
    "ts": null,
    "headline": "JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer",
    "summary": "Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.",
    "url": "https://finnhub.io/api/news?id=5fd8f76625cad9aa6e2e500f3a24cdf5b44cc920bc28ca17b28386c061f2e978",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749053820,
      "headline": "JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer",
      "id": 135036501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.",
      "url": "https://finnhub.io/api/news?id=5fd8f76625cad9aa6e2e500f3a24cdf5b44cc920bc28ca17b28386c061f2e978"
    }
  },
  {
    "ts": null,
    "headline": "J&J may take a softer tariff hit after US-China pause, CFO says",
    "summary": "Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with China and Europe and Section 232 investigations are ongoing.",
    "url": "https://finnhub.io/api/news?id=55813b2307364b78dcf347abb7c8f140ea1f1f648d96110febf47f3c67f9c8ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749027600,
      "headline": "J&J may take a softer tariff hit after US-China pause, CFO says",
      "id": 135009836,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with China and Europe and Section 232 investigations are ongoing.",
      "url": "https://finnhub.io/api/news?id=55813b2307364b78dcf347abb7c8f140ea1f1f648d96110febf47f3c67f9c8ed"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson MedTech introduces automated system for surgical efficiency",
    "summary": "The system features increased reverse energy to aid in broach removal and push-to-lock adaptors for secure connections.",
    "url": "https://finnhub.io/api/news?id=b8430e09a1eb6e1257aa247e2fa9ed3c469f89263feb2b4a577672ba855208f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749026890,
      "headline": "Johnson & Johnson MedTech introduces automated system for surgical efficiency",
      "id": 135009837,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The system features increased reverse energy to aid in broach removal and push-to-lock adaptors for secure connections.",
      "url": "https://finnhub.io/api/news?id=b8430e09a1eb6e1257aa247e2fa9ed3c469f89263feb2b4a577672ba855208f5"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Launches KINCISE 2 System, the Only Automated Surgical Impactor Approved for Knee and Hip Revision Procedures",
    "summary": "Palm Beach Gardens - Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, announced the launch of the KINCISE 2 Surgical Automated System, a next-generation automated...",
    "url": "https://finnhub.io/api/news?id=b2918beacad26a829a50e6d1149f58a6b0582457c3206017491877d4e9998510",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749019167,
      "headline": "Johnson & Johnson Launches KINCISE 2 System, the Only Automated Surgical Impactor Approved for Knee and Hip Revision Procedures",
      "id": 135007528,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Palm Beach Gardens - Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, announced the launch of the KINCISE 2 Surgical Automated System, a next-generation automated...",
      "url": "https://finnhub.io/api/news?id=b2918beacad26a829a50e6d1149f58a6b0582457c3206017491877d4e9998510"
    }
  },
  {
    "ts": null,
    "headline": "J&J: promising results in multiple myeloma",
    "summary": "Johnson & Johnson announces positive initial Phase 1 results for JNJ-79635322 , an investigational trispecific antibody for patients with relapsed or refractory multiple myeloma. In the 36 patients...",
    "url": "https://finnhub.io/api/news?id=0f3ce02516bc373477882687860ce9c071e4eab0d242378a8d1974d9597fa990",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749018850,
      "headline": "J&J: promising results in multiple myeloma",
      "id": 135007492,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announces positive initial Phase 1 results for JNJ-79635322 , an investigational trispecific antibody for patients with relapsed or refractory multiple myeloma. In the 36 patients...",
      "url": "https://finnhub.io/api/news?id=0f3ce02516bc373477882687860ce9c071e4eab0d242378a8d1974d9597fa990"
    }
  }
]